Sulfasalazine & Ulcerative Colitis (UC)

Sulfasalazine is a well-established medication that has been approved for the treatment of ulcerative colitis (UC) by both the FDA and EMA for many years. It continues to be a cornerstone therapy in managing UC, particularly for patients with mild to moderate forms of the disease. This drug is acknowledged as one of the earliest effective treatments developed for this condition (1, 2, 3)

References:

(1) Sebastian et al. 2024 Spartan Med Res J 9(3): 123397
(2) Hayllar & Bjarnason 1991 Gut 32(5): 462-3
(3) Freeman 2012 Clin Med Insights Gastroenterol 5: 77-83

see also:
Ulcerative colitis (UC)